argenx SE
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
Registration date
08 may 2026 - 23:20
Statutory name
argenx SE
Title
argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG
Date last update: 11 May 2026